Y Combinator

Founded in 2005, Y Combinator is a California-based startup accelerator and early-stage venture capital firm. It provides funding, mentorship, and resources to early-stage companies across various industries, with a focus on technology, healthcare, and finance. The organization helps founders refine their business models and products through an intensive three-month program in Silicon Valley, culminating in Demo Day presentations to investors.

Gustaf Alströmer

Partner

Tim Brady

Partner

Dalton Caldwell

Managing Director

Adora Cheung

Partner

Nic Dardenne

Principal

Nicolas Dessaigne

Partner

Aaron Epstein

Group Partner

Brad Flora

Partner

Jared Friedman

Partner

Anu Hariharan

Partner

Diana Hu

Partner

Reshma Khilnani

Partner

Pete Koomen

Visiting Group Partner

Carolynn Levy

Partner

Jon Levy

Managing Director

David Lieb

Partner

Jessica Livingston

Partner

Simon Lu

Principal

Kat Manalac

Managing Partner

Eric Migicovsky

Partner

Kirsty Nathoo

Partner

Geoff Ralston

President

Ali Rowghani

Managing Partner

Surbhi Sarna

Partner

Harj Taggar

Group Partner

Garry Tan

President

Matt Bogrand

Senior Associate

Past deals in Health Diagnostics

Frekil

Pre Seed Round in 2025
Frekil provides an AI-assisted platform for annotating and managing medical imaging datasets used in AI development and clinical research. The platform enables rapid, accurate annotation of X-rays, CTs, and MRIs for applications such as AI training, clinical trials, and FDA submissions. It combines real-time quality control, consensus checks, and advanced 3D visualization to speed up annotation while maintaining high accuracy. The system also tracks annotator performance and supports custom workflows to improve labeling quality and efficiency. Serving medical startups, research laboratories, hospitals, and pharmaceutical companies, Frekil aims to reduce costs, enhance data quality, and de-risk the path to regulatory approvals by delivering end-to-end dataset management for medical imaging projects.

Sohar Health

Seed Round in 2025
Sohar Health is a technology company that provides an API-based platform for behavioral health organizations. Its key offerings include automated eligibility verification and AI-powered medical coding, aiming to streamline workflows, enhance patient intake, and boost revenue.

Olio Labs

Venture Round in 2025
Olio Labs is a biotechnology company focused on developing combination therapeutics that leverage artificial intelligence to enhance treatment efficacy and reduce side effects. By employing automated discovery methods, the company analyzes protein interactions in the body, allowing for a more comprehensive approach to therapeutic design. Unlike traditional methods that typically target a limited number of proteins, Olio Labs' innovative strategy aims to create effective treatment solutions that consider a wider range of interacting proteins, ultimately improving patient outcomes.

Mito Health

Seed Round in 2025
Mito Health is an AI-powered medical healthtech that provides technological advances to revolutionize the future of personalized preventative care.

Phoenix Health

Series A in 2025
Phoenix Digital Health is a digital healthcare platform that offers telehealth solutions for men, providing access to virtual consultations, health assessments, treatment plans, and ongoing support for various health concerns, including sexual health, mental health, and chronic conditions, while ensuring that users can connect with licensed healthcare professionals through secure messaging and video calls, facilitating convenient and discreet healthcare management tailored to individual needs.

Vocality Health

Pre Seed Round in 2025
Vocality Health specializes in a Voice AI platform that facilitates medical language translation, improving communication within the healthcare sector. Their AI-driven system offers real-time, accurate, and clinically secure translation of voice and video content, allowing healthcare professionals to communicate effectively in any language, thereby reducing the need for human translators and associated costs.

Paratus Health

Pre Seed Round in 2025
Paratus Health offers a software application that automates pre-appointment patient interviews, benefiting doctors by saving time and enhancing accuracy. The platform, an AI-based voice intake nurse, proactively contacts patients via simple phone calls, eliminating the need for additional software or training for patients. It conducts comprehensive interviews, capturing detailed medical histories and symptoms, and provides healthcare providers with valuable insights before each appointment. This enables healthcare professionals to leverage advanced technology for tasks like patient intake and ongoing care management, ultimately improving the efficiency of clinical facilities.

Mecha Health

Seed Round in 2025
Mecha Health is a health technology company that specializes in developing digital tools for remote injury assessment, monitoring, and treatment planning. Its core product is an AI-based healthcare platform that focuses on medical image reporting, specifically for chest X-rays. The platform uses AI to identify and analyze key regions of interest, providing detailed insights and accurate findings that radiologists can trust. This streamlines the reporting process, enhances accuracy, and ultimately improves patient care.

HealthKey

Pre Seed Round in 2025
HealthKey offers AI-powered solutions for healthcare professionals, transforming extensive medical records into concise patient outlines. The platform enables efficient chart preparation in 90 seconds, helping healthcare providers remember patient histories, improve patient experiences, and close care gaps. HealthKey's services include summarizing patient records, generating diagnosis possibilities, and providing HIPAA-compliant AI solutions to streamline healthcare workflows.

Amby Health

Pre Seed Round in 2025
Amby Health specializes in enhancing emergency medical services (EMS) through innovative technology. It offers an AI-powered software platform that automates data ingestion and decision support, streamlining quality reviews and billing processes. This enables emergency medical teams to concentrate on patient care, reducing administrative burdens and optimizing resource allocation.

Collate

Seed Round in 2025
Collate creates and streamlines documentation for drug development, medical device, and diagnostic companies from concept to market using artificial intelligence. They produce accurate documentation for the life sciences industry, which speeds up innovations that can save lives.

Tuva Health

Seed Round in 2024
Tuva Health develops open source software that cleans, normalizes, and transforms unstructured healthcare data. Based in Salt Lake City, Utah, the company provides data management tools and services that fix data quality issues in raw claims and medical records. Its software enables providers to unify disparate data, enrich records, and quality-test data to support analytics, artificial intelligence development, and real-world evidence programs, helping organizations assemble reliable data blocks for advanced reporting and decision making.

Orange Health Labs

Venture Round in 2024
Orange Health is a health technology company that facilitates remote diagnostic lab services for patients, allowing doctors to provide real-time care. Its platform focuses on patient-centric home sample collection and testing, aiming to make healthcare more accessible and efficient.

Helpcare AI

Pre Seed Round in 2024
Helpcare AI is a health technology company that uses artificial intelligence to streamline care coordination for healthcare organizations. Its platform autonomously handles tasks such as patient outreach, scheduling, and report generation, helping healthcare providers to increase patient intake and reduce administrative burden on staff.

OpenClinic

Pre Seed Round in 2024
OpenClinic is an AI platform that helps doctors or hospitals to open their own digital health clinics.

HYBRD

Pre Seed Round in 2024
HYBRD is a technology company that specializes in creating a unified training platform for elite athletes who engage in multiple types of exercise, such as cardio and weightlifting. The company's mobile application integrates with top wearable devices to consolidate all workout data, making it easy for users to track their training load, monitor holistic progress over time, and compete with friends in innovative ways. HYBRD aims to address the challenge faced by hybrid athletes who previously had to use separate tools for different types of exercise, providing a comprehensive solution for managing and optimizing their training.

Ember Copilot

Pre Seed Round in 2024
Ember Copilot is a software development company specializing in healthcare technology. It provides a platform designed to streamline health insurance processes, particularly reducing administrative burdens and optimizing reimbursement procedures. The platform captures and transcribes medical sessions, generates visit summaries, progress notes, and treatment plans, supporting multiple languages and accents to ensure effective communication in diverse healthcare settings. This enables surgeons to significantly reduce time spent on documentation, electronic health records, and administrative tasks, including insurance documentation.

Reticular

Pre Seed Round in 2024
Reticular is a biotechnology research firm that specializes in AI-driven drug discovery. It develops AI-powered interpretability tools to understand and control the decision-making processes of biological AI models, particularly in protein engineering. This enables researchers and developers to build reliable and predictable AI systems for drug discovery and other bioengineering applications, even with limited data.

HealthSpark

Pre Seed Round in 2024
HealthSpark is a technology company that specializes in streamlining administrative tasks for physical therapists. Its platform automates insurance processes, schedules appointments, and manages patient charts, reducing paperwork and allowing therapists to focus more on patient care. Additionally, the platform integrates secure patient data management, telemedicine capabilities, real-time analytics, and appointment scheduling tools, empowering patients with timely access to their health information and contributing to improved clinical outcomes and more efficient healthcare operations.

Centaur Labs

Series B in 2024
Centaur Labs provides a platform for expert data annotation services, specializing in medical, scientific, and other complex datasets. It leverages a global network of tens of thousands of students and professionals to deliver accurate and scalable solutions.

Mito Health

Pre Seed Round in 2024
Mito Health is an AI-powered medical healthtech that provides technological advances to revolutionize the future of personalized preventative care.

Mdhub

Pre Seed Round in 2024
Mdhub is a technology company specializing in mental health. It offers a clinical AI assistant designed for mental health clinicians, automating the creation of structured clinical notes, patient summaries, and treatment plans. This streamlines administrative tasks, potentially saving clinicians up to two hours per day. The platform adheres to HIPAA's data processing and storage protocols, ensuring the security and privacy of patient information. By reducing manual documentation, Mdhub enables clinicians to focus more on patient treatment and care.

Codes Health

Pre Seed Round in 2024
Codes Health operates an automation platform that streamlines the collection of patient medical records. It uses artificial intelligence to gather and analyze documents from various sources, such as healthcare providers and patients, prior to the first appointment. This enables healthcare providers to efficiently obtain a patient's medical history.

Driftly

Pre Seed Round in 2024
Driftly is a home health agency that operates an AI-powered platform to optimize home care services. The platform uses historical data to match clinicians with patients, optimizes logistics to minimize travel time, and continuously reoptimizes schedules in real-time. This improves nurse utilization, reduces hospital admissions, and enables healthcare professionals to deliver better patient outcomes and operational efficiency.

Candid Health

Series B in 2024
Candid Health is a platform that automates revenue cycle management for healthcare providers by integrating with existing infrastructure and using machine learning and artificial intelligence to streamline medical billing, coding, and claims processing. It delivers end-to-end automation to reduce administrative burdens, increase operational efficiency, and accelerate reimbursement, enabling clinics and hospitals to focus more on delivering high-quality, affordable care.

Piramidal

Seed Round in 2024
Piramidal is a technology company specializing in artificial intelligence software for neurological health. It converts brain activity data into user-friendly health information, aiding in the diagnosis of various neurological diseases. The company's AI platform aims to enhance neurological diagnosis, treatment, and monitoring, providing swift and accurate patient assessments.

Reshape Biotech

Series A in 2024
Reshape Biotech is a company that specializes in developing advanced lab robots aimed at automating routine tasks for microbiologists, such as filling plates and analyzing images. Their innovative platform integrates robotics with machine learning to facilitate data-driven experimentation. By designing each robot to perform specific tasks rather than relying on a single multitasking unit, Reshape Biotech's technology helps alleviate workload and enhances efficiency in laboratory settings. This approach allows researchers and engineers to leverage automation alternatives, enabling them to focus more on critical aspects of their work and improve overall productivity.

RadMate AI

Pre Seed Round in 2024
RadMate AI specializes in an artificial intelligence-driven radiology dictation platform. This platform reads radiology images and generates comprehensive reports, allowing radiologists to review and submit them, thereby enhancing efficiency and freeing up more time for patient care.

Hona AI

Pre Seed Round in 2024
Hona AI is an AI data platform that collects and maintains healthcare history and records of patients.

Selera Medical

Pre Seed Round in 2024
Selera Medical is focused on creating innovative device-based treatments for heart failure, specifically targeting fluid overload in affected patients. The company aims to develop a minimally invasive procedure that utilizes the body's natural fluid regulation mechanisms to effectively remove excess fluid. This approach is designed to alleviate common symptoms associated with heart failure, such as shortness of breath and fatigue, while also reducing the frequency of hospitalizations. By enhancing the overall health and quality of life for patients, Selera Medical seeks to make a significant impact in the management of heart failure.

Scritch

Pre Seed Round in 2024
Scritch provides what you need to start your own practice or expand an existing one. Scritch promotes new patients via its membership program.

Piramidal

Pre Seed Round in 2024
Piramidal is a technology company specializing in artificial intelligence software for neurological health. It converts brain activity data into user-friendly health information, aiding in the diagnosis of various neurological diseases. The company's AI platform aims to enhance neurological diagnosis, treatment, and monitoring, providing swift and accurate patient assessments.

ParcelBio

Pre Seed Round in 2024
ParcelBio is a biotechnology company specializing in the development of a novel, programmable method for safely and precisely delivering messenger RNA (mRNA) to diverse cell types within the body. Their technology aims to create targeted, potent, and durable RNA therapeutics, with the potential to treat a wide range of diseases, including cancer, genetic disorders, and infectious diseases.

Stellar Sleep

Seed Round in 2024
Stellar Sleep is a developer of an innovative digital application specifically designed to assist individuals suffering from chronic insomnia, a condition affecting 25 million Americans. Unlike superficial solutions such as meditation or melatonin, which often do not address the underlying psychological challenges of insomnia, Stellar Sleep's approach employs evidence-based sleep psychology techniques. The application incorporates features such as soundscapes, sleep music, bedtime stories, and relaxation exercises, along with an algorithm that analyzes sleep patterns to optimize sleep schedules for deeper rest. Founded by two chronic insomnia sufferers, Stellar Sleep aims to provide effective management tools tailored for those struggling with persistent sleep issues, addressing the significant gap in resources available for this condition.

Encellin

Series A in 2023
Encellin Inc., established in 2016, is a biotechnology company based in San Francisco, California. It specializes in developing innovative thin-film cell encapsulation devices for cell-based therapeutics, aiming to improve the lives of patients with chronic diseases initially focusing on Type 1 diabetes. The company's technology enables encapsulated cells to function as smart molecular factories, providing potential therapeutic solutions.

InpharmD

Seed Round in 2023
InpharmD offers an AI-assisted, centralized clinical information platform for healthcare providers, especially clinical pharmacists. It consolidates summaries of reputable medical studies to reduce repetitive searching and support faster, more informed clinical decisions. By combining pharmacist expertise with artificial intelligence, the service provides a database of concise, evidence-based guidance to help clinicians access relevant information efficiently. Bootstrapped since 2018, InpharmD has expanded to multiple health systems, including adding its 8th health system, and has surpassed $1,000,000 in annual recurring revenue with strong year-over-year growth. The company focuses on improving access to high-quality medical evidence to support patient care.

Fortuna Health

Seed Round in 2023
Fortuna Health specializes in simplifying Medicaid access for consumers. Its core business is a user-friendly platform that guides individuals through the complexities of eligibility, enrollment, and renewal processes, ensuring they maintain continuous coverage and receive timely notifications for recertification and renewal. This streamlined approach helps reduce care gaps and ensures clients are enrolled in the most suitable medical plan programs.

Pair Team

Series A in 2023
Pair Team provides healthcare coordination services focused on underserved and vulnerable communities. It deploys a dedicated, tech-enabled care team—including community health workers, registered nurses, and behavioral health clinicians—to offer personalized, holistic support to Medicaid and Medicare patients and other low-income individuals facing barriers to care such as transportation, housing and food insecurity, and limited mobile access. The company acts as an extension of safety-net primary care systems, helping them deliver patient-centered care while integrating with community-based organizations. It is building a care delivery platform to standardize clinical practices, streamline administrative tasks, and enable clinicians to spend more time with patients.

Sohar Health

Seed Round in 2023
Sohar Health is a technology company that provides an API-based platform for behavioral health organizations. Its key offerings include automated eligibility verification and AI-powered medical coding, aiming to streamline workflows, enhance patient intake, and boost revenue.

Clinikally

Seed Round in 2023
Clinikally is India’s first integrated Telemedicine & E-Pharmacy platform specializing in Dermatology. It connects users with expert dermatologists within 30 minutes, providing personalized treatment plans and delivering Rx-grade products directly to their doorstep.

LifestyleRx

Grant in 2023
LifestyleRx is a healthcare platform focused on providing insurance-covered virtual care for individuals with Type 2 Diabetes. The company offers a physician-led program designed to help patients manage their health effectively. Through medical sessions and group consultations, LifestyleRx aims to reduce insulin resistance, decrease or eliminate the need for medications, and restore normal blood sugar levels. By guiding patients in taking control of their health, the platform empowers diabetic individuals to improve their overall well-being and achieve better health outcomes.

Wattson Health

Pre Seed Round in 2023
Wattson Health operates a technology platform that automates routine tasks in pharmacies, such as prescription management, to enhance operational efficiency and reduce errors. This allows pharmacy staff to focus more on patient care, improving service quality.

Kips Health

Pre Seed Round in 2023
Kips Health is a software company that specializes in patient engagement for musculoskeletal medicine providers. Its core product is a platform that facilitates appointment bookings for individuals seeking help with injury, health, and fitness-related issues, particularly athletes. The platform also enables physical therapists to automatically collect reimbursements for remote therapeutic monitoring services.

Health Harbor

Pre Seed Round in 2023
Health Harbor is a healthcare data platform that focuses on automating billing processes for private practices. The platform streamlines the input of patient information and facilitates requests for eligibility and claims. Utilizing artificial intelligence, Health Harbor's system can directly communicate with insurance companies to retrieve necessary information. This automation allows clients to easily track the status of their requests and claims, simplifying the billing process and enhancing operational efficiency for healthcare providers.

Cleancard

Seed Round in 2023
Cleancard is a company focused on revolutionizing cancer screening by leveraging synthetic biology and artificial intelligence. It develops innovative at-home testing solutions that allow individuals to screen for prostate, bladder, and ovarian cancers from the comfort of their homes. By utilizing a novel approach, Cleancard's diagnostics can deliver robust results from a urine sample within just 30 minutes. The company's technology aims to simplify the cancer detection process, making it as accessible as a pregnancy test, while continuously expanding the range of conditions that can be identified from a single sample. Through its advancements, Cleancard strives to provide reliable cancer diagnostics, enabling patients to pursue appropriate treatments with ease and confidence.

Olio Labs

Seed Round in 2023
Olio Labs is a biotechnology company focused on developing combination therapeutics that leverage artificial intelligence to enhance treatment efficacy and reduce side effects. By employing automated discovery methods, the company analyzes protein interactions in the body, allowing for a more comprehensive approach to therapeutic design. Unlike traditional methods that typically target a limited number of proteins, Olio Labs' innovative strategy aims to create effective treatment solutions that consider a wider range of interacting proteins, ultimately improving patient outcomes.

Stellar Sleep

Seed Round in 2023
Stellar Sleep is a developer of an innovative digital application specifically designed to assist individuals suffering from chronic insomnia, a condition affecting 25 million Americans. Unlike superficial solutions such as meditation or melatonin, which often do not address the underlying psychological challenges of insomnia, Stellar Sleep's approach employs evidence-based sleep psychology techniques. The application incorporates features such as soundscapes, sleep music, bedtime stories, and relaxation exercises, along with an algorithm that analyzes sleep patterns to optimize sleep schedules for deeper rest. Founded by two chronic insomnia sufferers, Stellar Sleep aims to provide effective management tools tailored for those struggling with persistent sleep issues, addressing the significant gap in resources available for this condition.

SiPhox Health

Seed Round in 2023
SiPhox Health, based in Cambridge, Massachusetts, specializes in designing and manufacturing innovative diagnostic solutions. The company develops next-generation diagnostics infrastructure, including at-home test kits and central lab systems. Their flagship product is a disposable biosensor cartridge that assesses 17 blood biomarkers, providing insights into inflammation, hormonal health, metabolic fitness, and cardiovascular health. SiPhox Health's platform merges biochemistry, photonic chip technology, integrated photonics, electronics, and microfluidics to enable sensitive readouts of immunoassays and nucleic acid tests, facilitating point-of-need and at-home diagnostics.

Gradia Health

Seed Round in 2023
Gradia Health is a digital platform designed to support clinics in managing patients with chronic conditions. It provides timely health information to patients via their phones, including pre- and post-visit content tailored to their specific condition.

MediSearch

Seed Round in 2023
MediSearch is a technology company that develops a search engine platform. This platform is designed to deliver direct, science-based answers to medical questions, empowering users to make informed decisions about their health and well-being. It offers a user-friendly interface, expert-curated information, and reliable sources, making it a trusted resource for those seeking health or bioscience insights.

MantleBio

Seed Round in 2023
MantleBio is a medical technology company focused on developing software that enhances data-driven discovery in the biotechnology sector. Its platform is designed to manage and analyze biological data, streamlining the drug discovery process. By providing tools that assist scientists and computational biologists in handling high-throughput experiments, MantleBio enables biotech companies to utilize advancements in computational science and machine learning effectively. Through its innovative approach, the company aims to accelerate the development of new therapeutics and improve research efficiency within the industry.

MICSI

Seed Round in 2023
MICSI is a developer of advanced medical image processing technology that utilizes random matrix theory denoising to enhance image quality. The company's platform is designed to improve the Signal-To-Noise Ratio in Magnetic Resonance Imaging (MRI), which results in higher resolution and better image quality. MICSI's solutions facilitate the development of image processing algorithms that reduce MRI scan times, thereby optimizing clinical workflows. This technology is particularly beneficial for medical professionals involved in brain mapping and preoperative studies, as it enables more effective receptor-mediated transcytosis and MP-PCA image reconstruction. Through its innovative approach, MICSI aims to advance the field of medical imaging, enhancing diagnostic capabilities and patient outcomes.

Alfie Health

Pre Seed Round in 2023
Alfie Health is a virtual obesity management clinic that focuses on sustainable weight loss through a combination of precision medicine and behavioral change. Utilizing proprietary AI clinical decision support technology, Alfie Health continuously analyzes patient data, including medication history and metabolic information, to tailor individualized weight management plans. The platform also offers regular telehealth visits, ensuring ongoing medical supervision and support for users. Additionally, patients are connected with certified health coaches who assist in determining the most effective medication combinations to achieve their weight loss goals. This innovative approach aims to provide comprehensive care from the convenience of patients' homes.

Intelliga Health

Pre Seed Round in 2023
Intelliga Health is an artificial intelligence company focused on optimizing insurance workflows for medical practices. Its platform automates the process of insurance authorization appeals by analyzing previous successful appeals to generate personalized appeal letters for healthcare providers. This approach not only saves time for medical professionals but also increases the likelihood of successful authorization for necessary treatments. In addition to managing appeal processes, Intelliga Health’s platform monitors technical infrastructure and ensures compliance, providing a comprehensive solution that enhances operational efficiency within healthcare settings.

BIOS

Series A in 2023
BIOS Health is a pioneering company focused on developing neural digital therapies by harnessing data-driven insights from the human nervous system. Co-founded by researchers from Cambridge University, the firm aims to revolutionize precision medicine through the identification of neural biomarkers that link nerve activity to various medical conditions. BIOS's innovative approach holds promise for treating chronic diseases such as hypertension, diabetes, rheumatoid arthritis, and neurodegenerative disorders like Parkinson's and Alzheimer's. The company's expertise encompasses a diverse range of fields, including neuroscience, machine learning, software engineering, and biotechnology, allowing it to create advanced solutions for improving the quality of life for individuals suffering from these conditions. Additionally, BIOS is engaged in developing prosthetic connectors that standardize the interface between bionic devices and the body's nervous and soft-tissue systems, enabling enhanced control and feedback for patients with prosthetics.

Scanbase

Pre Seed Round in 2023
Scanbase is a company that focuses on enhancing the diagnostic journey for patients by developing innovative digital care planning and management tools. Its platform transforms traditional analog tests into digital workflows that integrate with application programming interfaces (APIs). This capability allows medical companies to analyze patient risk through photographs of rapid diagnostic tests and provide immediate results. By leveraging advanced computer vision technology, Scanbase aims to improve the efficiency and accuracy of at-home diagnostics, positioning itself as a leader in the evolving landscape of diagnostic medicine. The company is adaptable and responsive to unique situations, ensuring that it remains at the forefront of technological advancements in healthcare.

Lavo Life Sciences

Pre Seed Round in 2023
Lavo Life Sciences is an early-stage company specializing in drug development software tools. It leverages AI-accelerated quantum chemistry methods to predict pharmaceutical properties more accurately and cost-effectively than traditional solutions.

Diffuse Bio

Pre Seed Round in 2023
Diffuse Bio is a biotechnology company focused on creating an automated AI software platform for drug design. The company leverages advancements in generative AI to develop innovative solutions in the pharmaceutical industry. Over the past six years, Diffuse Bio has made significant strides in AI protein design, achieving milestones such as the first experimental validation of AI-generated proteins and the application of diffusion models for understanding protein structure and sequence. By utilizing its platform, the company aims to streamline the drug discovery process, addressing critical health challenges such as flu, cancer, and COVID-19, ultimately improving treatment options for patients and healthcare providers.

Latent

Pre Seed Round in 2023
Latent is a company focused on developing medical language models aimed at reducing operational costs in the healthcare sector. By analyzing Electronic Health Records (EHR), Latent's platform streamlines the insurance authorization process, efficiently retrieving and surfacing the most relevant information needed for decision-making. This innovative approach enables healthcare organizations to automate their operations, ultimately enhancing efficiency and reducing overhead.

Untether Labs

Pre Seed Round in 2023
Untether Labs specializes in workforce management software for the healthcare industry. Its platform enables healthcare professionals to efficiently manage schedules, scale providers, and optimize margins while reducing burnout and patient wait times.

Kivo Health

Venture Round in 2023
Kivo Health is a telehealth company specializing in lung care. It offers an eight-week clinical program led by live therapists, aiming to reduce symptoms and manage chronic obstructive pulmonary disease.

Opkit

Seed Round in 2023
Opkit is an innovative startup supported by Y Combinator that focuses on transforming communication within the healthcare sector through its AI-driven phone calling platform. The company's HIPAA-compliant software automates essential phone calls for healthcare provider organizations, streamlining routine processes such as insurance verification. By offering automated eligibility checks, Opkit helps healthcare providers determine crucial details regarding patients' insurance plans, including their active status and network coverage, as well as benefits related to copays and deductibles. This comprehensive approach enables healthcare providers to enhance operational efficiency while ensuring that patients receive quality and affordable care.

Reshape Biotech

Seed Round in 2023
Reshape Biotech is a company that specializes in developing advanced lab robots aimed at automating routine tasks for microbiologists, such as filling plates and analyzing images. Their innovative platform integrates robotics with machine learning to facilitate data-driven experimentation. By designing each robot to perform specific tasks rather than relying on a single multitasking unit, Reshape Biotech's technology helps alleviate workload and enhances efficiency in laboratory settings. This approach allows researchers and engineers to leverage automation alternatives, enabling them to focus more on critical aspects of their work and improve overall productivity.

Wyndly

Seed Round in 2023
Wyndly is a company that specializes in personalized allergy treatment and online care. It offers clinically tested therapies designed to provide long-term relief from allergies. Wyndly's expert providers work closely with clients to develop tailored treatment plans that address the root causes of allergies, which are often not effectively managed by traditional antihistamines and nasal sprays. The company's innovative approach includes the use of allergy drops, which aim to deliver a more affordable and convenient form of immunotherapy. Overall, Wyndly focuses on enhancing the quality of life for individuals suffering from allergies by offering effective, customized solutions.

Metriport

Seed Round in 2022
Metriport is an open-source platform designed to facilitate the access and exchange of medical data for healthcare organizations. By enabling users to retrieve comprehensive patient medical information in a standardized format, the platform enhances the sharing of electronic health records, medications, allergies, lab results, and imaging data. This functionality aims to improve data exchange among healthcare providers and streamline operations, ultimately supporting better patient care.

Angle Health

Series A in 2022
Founded in 2019, Angle Health specializes in providing modern health insurance solutions tailored for startups. It offers a comprehensive platform that combines AI-enabled tools, virtual care access, and customizable benefits to streamline administrative tasks and deliver personalized healthcare management.

Disclo

Venture Round in 2022
Disclo is a HIPAA compliant platform enabling employers to collect, verify, and manage employee health disclosures and accommodation requests. Disclo helps employees secure the enhancements and protections they need to succeed in their careers without having to disclose their underlying medical condition to their employer.

KemNet

Venture Round in 2022
KemNet is a Canadian healthcare technology company based in Edmonton that serves pharmacies in Alberta. Founded in 2022, it provides software to streamline the custom medication ordering process, track compounded drugs, and ensure regulatory compliance. The platform enables pharmacies to address patient-specific needs, manage drug shortages, and maintain safety and transparency in operations by supporting accurate ordering, documentation, and oversight of compounded medications.

iollo

Venture Round in 2022
iollo, founded in 2022 and based in San Francisco, offers metabolomics testing to support wellbeing and aging. The company develops at-home blood test kits that monitor biomarkers across heart, kidney, liver function, the microbiome, and metabolic health, measuring molecules in blood to provide personalized insights. Its service links biomarker data to dietary, behavioral, and therapeutic interventions, delivering recommendations aimed at improving wellness and managing aging. iollo emphasizes convenient, at-home testing and automated interpretation to help individuals make informed lifestyle choices and track health over time.

Signatur Biosciences

Venture Round in 2022
Signatur Biosciences, founded in 2022, is focused on advancing molecular diagnostics through a novel PCR testing platform. The company aims to make precision diagnostics more accessible by utilizing the molecular mechanisms of PCR to simplify the detection and interpretation of a comprehensive panel of RNA biomarkers into a single test. This innovative approach includes a smart kit that is compatible with existing machines and readily available reagents, allowing clinicians to seamlessly integrate the technology into their current clinical workflows and infrastructure.

Morf Health

Venture Round in 2022
Morf Health streamlines healthcare technology integration by collecting, structuring, and securely transmitting patient data between tools used for care delivery and business operations. This enables healthcare providers to efficiently manage patient intake data and send it to electronic health records.

Be Golden

Venture Round in 2022
Be Golden assists in measuring and managing inflammation levels. Founded in 2021 and is based in San Francisco, CA.

InVision Medical Technology

Venture Round in 2022
InVision Medical Technology develops an advanced medical imaging platform that leverages artificial intelligence to enhance the interpretation of cardiac ultrasounds. By integrating these AI tools into clinical workflows, the company aims to streamline the diagnosis process for healthcare professionals. This technology is designed to assist in the identification of undiagnosed diseases, particularly heart conditions, allowing doctors to quickly and accurately detect potential health issues. InVision is focused on improving patient outcomes through innovative solutions that facilitate timely and effective medical assessments.

Disclo

Pre Seed Round in 2022
Disclo is a HIPAA compliant platform enabling employers to collect, verify, and manage employee health disclosures and accommodation requests. Disclo helps employees secure the enhancements and protections they need to succeed in their careers without having to disclose their underlying medical condition to their employer.

Medplum

Seed Round in 2022
Medplum offers an open-source developer platform designed to simplify healthcare application development. It focuses on streamlining workflow automation, secure data storage, and providing UI components tailored for healthcare.

Bristle

Seed Round in 2022
Bristle analyzes users' saliva samples to assess oral health status, including risks of cavities, gum disease, and bad breath. It then provides personalized insights and recommendations to optimize and maintain oral health.

Clinikally

Pre Seed Round in 2022
Clinikally is India’s first integrated Telemedicine & E-Pharmacy platform specializing in Dermatology. It connects users with expert dermatologists within 30 minutes, providing personalized treatment plans and delivering Rx-grade products directly to their doorstep.

Kindly

Seed Round in 2022
Kindly Health is a diagnostics platform focused on sexual care and performance health, catering to both men and women. The company offers comprehensive solutions for sperm health and sexual performance in men, as well as addressing issues such as low libido, polycystic ovary syndrome (PCOS), irregular periods, and menstrual pain in women. Kindly Health enhances accessibility to its services by providing at-home diagnostic tests, such as semen analyses and PCOS assessments, along with telehealth consultations and supplements. Additionally, Kindly Health has developed an AI and computer vision tool aimed at improving the embryo selection process in fertility treatments, thereby increasing the success rate of in vitro fertilization (IVF). Through these innovations, Kindly Health strives to make fertility care and sexual health solutions more affordable and accessible for patients.

Malama Health

Pre Seed Round in 2022
Malama Health improves pregnancy-related outcomes by providing software that enhances the care offered by OB/GYNs. Its platform offers a glucose tracker, identifies food triggers, provides one-on-one coaching, and delivers actionable insights to optimize maternal health.

Corveus Medical

Non Equity Assistance in 2022
Corveus Medical is a medical device company focused on innovative solutions for preventing heart failure. The company is developing a neuromodulation device designed to perform nerve ablation through a catheter-based approach. This minimally invasive technology aims to effectively target and access specific tissues, offering a novel treatment option for heart failure. By addressing both the clinical and economic challenges associated with this condition, Corveus Medical seeks to improve patient outcomes and enhance the overall management of heart failure.

Syrona Health

Seed Round in 2022
Syrona Health is a digital health company focused on personalized gynecological care throughout various life stages, including menstrual health, fertility, parenthood, and menopause. It offers a virtual health support platform that integrates software and hardware to enhance gynecological health outcomes. The company's solutions address conditions such as endometriosis, polycystic ovary syndrome (PCOS), and gynecological cancers, enabling women to monitor their health independently. Syrona Health also provides at-home clinical testing and online counseling, allowing women to manage their gynecological health proactively without relying on lengthy clinic visits for diagnostics.

Orange Health Labs

Series B in 2022
Orange Health is a health technology company that facilitates remote diagnostic lab services for patients, allowing doctors to provide real-time care. Its platform focuses on patient-centric home sample collection and testing, aiming to make healthcare more accessible and efficient.

Isabl

Seed Round in 2022
Isabl is a startup focused on developing advanced diagnostic assays for cancer through whole-genome and RNA sequencing. Founded in 2020 after incubating its technology at Memorial Sloan Kettering Cancer Center from 2015 to 2019, Isabl participated in the Winter 2020 batch of Y Combinator and has attracted significant funding, including a $3 million seed round and a $2 million SBIR grant from the National Cancer Institute. The company received FDA Breakthrough Device designation in 2021, recognizing the innovative nature of its cancer diagnostic tests. Isabl's platform is designed to efficiently analyze cancer patients' genomes while ensuring data reproducibility and supporting bioinformatics operations, thereby facilitating data-driven automation for oncology centers. Led by founders Dr. Elli Papaemmanuil, Dr. Andrew Kung, and Juan Medina, Isabl's team combines expertise in precision medicine, computational biology, and software engineering, focusing on biomarker discovery and clinical decision support for pediatric and rare solid cancers.

Anja

Seed Round in 2022
Anja Health is a personalized, doctor-backed company specializing in umbilical cord blood and placenta stem cell banking. It offers a convenient service for expecting parents by providing a collection kit to facilitate the preservation of stem cells immediately after birth. Anja Health allows for up to two minutes of delayed cord clamping, ensuring that the collection of stem cells is performed safely. Once the birth occurs, parents can notify Anja's team using the contact number on the kit, prompting a medical courier to collect and swiftly transport the kit to a lab within 72 hours. The company aims to make the preservation of these vital stem cells both easy and affordable, empowering parents with knowledge about stem cell banking and its potential benefits for future medical treatments.

Uh-Oh Labs

Venture Round in 2022
Uh-Oh Labs is a diagnostics and health technology company that works to improve public health by developing low-cost, accurate diagnostics. It also develops diagnostic tests through its Loop-de-Loop platform. They provide infectious disease testing, the COVID-19 Test, which includes a reusable instrument and disposable test kits.

Corveus Medical

Pre Seed Round in 2022
Corveus Medical is a medical device company focused on innovative solutions for preventing heart failure. The company is developing a neuromodulation device designed to perform nerve ablation through a catheter-based approach. This minimally invasive technology aims to effectively target and access specific tissues, offering a novel treatment option for heart failure. By addressing both the clinical and economic challenges associated with this condition, Corveus Medical seeks to improve patient outcomes and enhance the overall management of heart failure.

Alfie Health

Pre Seed Round in 2022
Alfie Health is a virtual obesity management clinic that focuses on sustainable weight loss through a combination of precision medicine and behavioral change. Utilizing proprietary AI clinical decision support technology, Alfie Health continuously analyzes patient data, including medication history and metabolic information, to tailor individualized weight management plans. The platform also offers regular telehealth visits, ensuring ongoing medical supervision and support for users. Additionally, patients are connected with certified health coaches who assist in determining the most effective medication combinations to achieve their weight loss goals. This innovative approach aims to provide comprehensive care from the convenience of patients' homes.

Starling Medical

Venture Round in 2022
Starling Medical is focused on creating a remote patient monitoring platform that facilitates at-home urine diagnostics, aiming to integrate seamlessly into everyday bathroom routines. The company designs healthcare devices that utilize mass spectroscopy-based sensors for continuous monitoring and early detection of health issues through urine analysis. By tracking changes in urine composition over time, Starling Medical's technology enables timely intervention for patients and healthcare providers, potentially preventing complications and reducing the need for hospitalizations. The organization is dedicated to developing predictive technology that enhances early detection of chronic health concerns, ultimately improving patient outcomes.

Ankr Health

Venture Round in 2022
Ankr Health uses AI and telemedicine to automate side effect management in cancer and surgical clinics. Founded in 2022 and is based in San Francisco, CA.

Tuva Health

Venture Round in 2022
Tuva Health develops open source software that cleans, normalizes, and transforms unstructured healthcare data. Based in Salt Lake City, Utah, the company provides data management tools and services that fix data quality issues in raw claims and medical records. Its software enables providers to unify disparate data, enrich records, and quality-test data to support analytics, artificial intelligence development, and real-world evidence programs, helping organizations assemble reliable data blocks for advanced reporting and decision making.

Alixia

Venture Round in 2022
Alixia is a medical research company focused on developing innovative therapeutics to combat cancer, aging, and inflammation. The company specializes in mitochondria-targeting therapeutics that aim to enhance drug discovery. Alixia employs a multidisciplinary approach, integrating biology, biophysics, computational chemistry, and clinical insights to create new treatment options. Its lead compounds are designed to disrupt metabolic and inflammatory triggers in cancer and quasi-cancerous cells within their microenvironment. Additionally, Alixia's mitochondrion regulators checkpoint system addresses chronic inflammation and improves metabolism by promoting the removal of dysfunctional mitochondria from cells. This approach enables healthcare professionals to enhance cognitive health, facilitate faster recovery from physical activities, and alleviate joint pain for patients.

Spot Health

Venture Round in 2022
Spot Health is a healthcare testing platform that facilitates telehealth companies in providing at-home laboratory tests to their patients. The company enables these businesses to order diagnostic tests through its API, managing the entire process from test ordering to analysis. By offering at-home collection kits, Spot Health allows patients to conveniently and efficiently assess their health conditions without the need for in-person laboratory visits. This innovative approach enhances accessibility to healthcare testing, streamlining the experience for both providers and patients.

MedMe

Seed Round in 2022
MedMe Health is a patient care platform that assists pharmacists in scheduling, conducting, and tracking clinical services both virtually and on-site. The platform employs proprietary algorithms to facilitate various medical services, including online scheduling, digital diagnosis, documentation filing, and automated follow-up appointments. By streamlining workflows and enhancing patient relationships, MedMe Health enables pharmacies to diversify their revenue streams and efficiently deliver clinical services at scale.

Starling Medical

Seed Round in 2022
Starling Medical is focused on creating a remote patient monitoring platform that facilitates at-home urine diagnostics, aiming to integrate seamlessly into everyday bathroom routines. The company designs healthcare devices that utilize mass spectroscopy-based sensors for continuous monitoring and early detection of health issues through urine analysis. By tracking changes in urine composition over time, Starling Medical's technology enables timely intervention for patients and healthcare providers, potentially preventing complications and reducing the need for hospitalizations. The organization is dedicated to developing predictive technology that enhances early detection of chronic health concerns, ultimately improving patient outcomes.

Serif Health

Seed Round in 2022
Serif Health is a company that specializes in healthcare price intelligence and contract management solutions. It develops software that enhances price transparency and analytics, aimed at improving reimbursements and negotiating contracts with health plans. The company's offerings include price estimators, data publishing tools, and benchmarking features designed to facilitate contracting negotiations and increase patient volume. By minimizing technology integration costs and streamlining processes, Serif Health enables hospitals and healthcare providers to strengthen their relationships with insurance companies and optimize financial performance.

RTHM

Seed Round in 2022
RTHM is a biotechnology company focused on enhancing patient care through the integration of remote clinical medicine and cutting-edge molecular and digital measurement technologies. The company operates a telehealth clinic that specializes in providing treatment for long COVID, utilizing innovative approaches to deliver virtual-first care for complex illnesses. By combining clinical research with advanced diagnostics, RTHM aims to accelerate the development and delivery of new treatments, ensuring that patients receive timely and effective care.

Athelas

Venture Round in 2022
Founded in 2002, Athelas develops and manufactures medical devices for remote patient monitoring. Its flagship product is an FDA-cleared blood diagnostic device that enables the detection of infections, inflammations, and malignancies. The company also offers sensors to monitor blood pressure, weight, glucose levels, and medication adherence.

Alfie Health

Pre Seed Round in 2021
Alfie Health is a virtual obesity management clinic that focuses on sustainable weight loss through a combination of precision medicine and behavioral change. Utilizing proprietary AI clinical decision support technology, Alfie Health continuously analyzes patient data, including medication history and metabolic information, to tailor individualized weight management plans. The platform also offers regular telehealth visits, ensuring ongoing medical supervision and support for users. Additionally, patients are connected with certified health coaches who assist in determining the most effective medication combinations to achieve their weight loss goals. This innovative approach aims to provide comprehensive care from the convenience of patients' homes.

Zeit Medical

Seed Round in 2021
Zeit Medical is a company focused on advancing the treatment of neurological injuries through innovative technology. Founded in 2019 by Urs Naber and Orestis Vardoulis, the company has developed a specialized headband that continuously monitors the electrical activity of the brain. This device integrates smoothly with existing electroencephalogram (EEG) systems and automates the pre-screening process, facilitating the annotation of extensive datasets. By identifying signature patterns in EEG readings, Zeit Medical enables physicians to diagnose and treat neurological conditions with greater precision, particularly in detecting the onset of strokes.

Pirouette Medical

Venture Round in 2021
Pirouette Medical specializes in developing portable and user-friendly auto-injectors. Its initial product is an epinephrine auto-injector for emergency treatment of severe allergic reactions, designed with a human-centered approach to address major pain points.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.